See What HealthDay Can Do For You
Contact Us

Clinical Trials Update: May 26, 2005

Bipolar Disorders (Pediatric) Osteoarthritis Kidney Disease

(HealthDay News) -- Here are the latest clinical trials, courtesy of CenterWatch:

Bipolar Disorders (Pediatric)

A six-month open-label clinical research study to evaluate the safety of Depakote ER in the treatment of mania associated with bipolar I disorder in children and adolescents. Eligible candidates must be between 10 and 17 years of age and weigh at least 60 lbs (27 kg), have a current psychiatric diagnosis of bipolar I disorder, manic or mixed episode and an outpatient in a manic or mixed episode. Research sites located throughout the United States.

More Information

Please see http://www.centerwatch.com/patient/studies/cat488.html.

-----

Osteoarthritis

The study doctor will give some participants an investigational gel for the treatment of osteoarthritis. Participants must be at least 40 years of age and have a diagnosis of dominant-hand OA for at least 12 months. Research site located in Arlington Heights, Ill.

More Information

Please see http://www.centerwatch.com/patient/studies/cat109.html.

-----

Kidney Disease

This study will assess the effect of anemia therapy in participants with both chronic kidney disease (CKD) and type 2 diabetes mellitus (DM). Participants must have signed, written informed consent, have an Hb less than or equal to 11.0 g/dL, and have CKD and DM. Research sites located in Arizona, Nebraska and Massachusetts.

More Information

Please see http://www.centerwatch.com/patient/studies/cat226.html.

-----

Copyright 2005 CenterWatch. All rights reserved.

Consumer News

HealthDay

HealthDay is the world’s largest syndicator of health news and content, and providers of custom health/medical content.

Consumer Health News

A health news feed, reviewing the latest and most topical health stories.

Professional News

A news feed for Health Care Professionals (HCPs), reviewing latest medical research and approvals.